Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methylene Chloride SCHEMBL4557546 | 1.00 | ALDH1A1 (0.48) | ALDH1A1TDP1TRPA1 | |
| Methylene Chloride SCHEMBL2456472 | 1.00 | ALDH1A1 (0.48) | ALDH1A1TDP1TRPA1 | |
| Methylene Chloride SCHEMBL6704394 | 1.00 | ALDH1A1 (0.48) | ALDH1A1TDP1TRPA1 | |
| Methylene Chloride SCHEMBL861591 | 1.00 | ALDH1A1 (0.48) | ALDH1A1TDP1TRPA1 | |
| Methylene Chloride SCHEMBL4304807 | 1.00 | ALDH1A1 (0.48) | ALDH1A1TDP1TRPA1 | |
| Methylene Chloride SCHEMBL3630221 | 1.00 | ALDH1A1 (0.48) | ALDH1A1TDP1TRPA1 | |
| Methylene Chloride SCHEMBL7695098 | 1.00 | ALDH1A1 (0.48) | ALDH1A1TDP1TRPA1 | |
| Methylene Chloride SCHEMBL5133360 | 1.00 | ALDH1A1 (0.48) | ALDH1A1TDP1TRPA1 | |
| Methylene Chloride SCHEMBL1395290 | 1.00 | ALDH1A1 (0.48) | ALDH1A1TDP1TRPA1 | |
| Methylene Chloride SCHEMBL5091282 | 1.00 | ALDH1A1 (0.48) | ALDH1A1TDP1TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112566897-B | Hydrophilic metal surface treatment agent | 化学电子有限公司 | 2022-03-01 | — | — | CN | disclosed |
| CN-108003196-B | Dinuclear metal complexes containing carbene ligands and use thereof in OLEDs | UDC 爱尔兰有限责任公司 | 2021-07-23 | — | — | CN | disclosed |
| CN-112566897-A | Hydrophilic metal surface treatment agent | 化学电子有限公司 | 2021-03-26 | — | — | CN | disclosed |
| CN-105246473-B | Fe (III) complex compound for the treatment of and prevention for iron deficiency symptoms and hypoferric anemia | 维福（国际）股份有限公司 | 2018-07-13 | — | — | CN | disclosed |
| EP-2050749-B1 | PYRIMIDINE DERIVATIVE AS PI3K INHIBITOR AND USE THEREOF | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2017-11-22 | — | — | EP | disclosed |
| US-9452152-B2 | Fe(III) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias | VIFOR (INTERNATIONAL) AG (CH) | 2016-09-27 | — | — | US | disclosed |
| CN-105246473-A | Fe(iii) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemia | VIFOR INT AG | 2016-01-13 | — | — | CN | disclosed |
| US-20150313864-A1 | Fe(III) Complex Compounds for the Treatment and Prophylaxis of Iron Deficiency Symptoms and Iron Deficiency Anemias | VIFOR (INTERNATIONAL) AG (CH) | 2015-11-05 | — | — | US | disclosed |
| US-8022205-B2 | Pyrimidine derivatives as PI3K inhibitor and use thereof | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2011-09-20 | — | — | US | disclosed |
| US-20100069629-A1 | PYRIMIDINE DERIVATIVES AS PI3K INHIBITOR AND USE THEREOF | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2010-03-18 | — | — | US | disclosed |
| EP-2050749-A1 | PYRIMIDINE DERIVATIVE AS PI3K INHIBITOR AND USE THEREOF | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2009-04-22 | — | — | EP | disclosed |
| US-7371742-B2 | Porphyrin derivatives for photodynamic therapy | INSTITUT CURIE (FR) | 2008-05-13 | — | — | US | disclosed |
| EP-1845096-A1 | 12-Aza-epothilones, process for their preparation and their use as antiproliferative agents | ETH Zürich (CH) | 2007-10-17 | — | — | EP | disclosed |
| WO-2007110214-A1 | 12-AZA-EP0THIL0NES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTIPROLIFERATIVE AGENTS | ETH Zürich (CH) | 2007-10-04 | — | — | WO | disclosed |
| US-20040259810-A1 | Porphyrin derivatives for photodynamic therapy | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2004-12-23 | — | — | US | disclosed |
| EP-1406914-A2 | PORPHYRIN DERIVATIVES FOR PHOTODYNAMIC THERAPY | Institut Curie (FR) | 2004-04-14 | — | — | EP | disclosed |
| WO-2003008430-A2 | PORPHYRIN DERIVATIVES FOR PHOTODYNAMIC THERAPY | INSTITUT CURIE (FR) | 2003-01-30 | — | — | WO | disclosed |
| EP-1279676-A1 | Porphyrin derivatives for photodynamic therapy | Institut Curie (FR) | 2003-01-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100069629-A1 | PYRIMIDINE DERIVATIVES AS PI3K INHIBITOR AND USE THEREOF | PIK3CA, AKT3, AKT1 | ALDH1A1 2102/4885TDP1 446/4885TRPA1 4291/4885 |
| US-20150313864-A1 | Fe(III) Complex Compounds for the Treatment and Prophylaxis of Iron Deficiency Symptoms and Iron Deficiency Anemias | FECH, SDHB, SLC40A1 | ALDH1A1 1539/4885TDP1 4796/4885TRPA1 4449/4885 |
| US-20040259810-A1 | Porphyrin derivatives for photodynamic therapy | PPOX, VHL, FAP | ALDH1A1 2327/4885TDP1 750/4885TRPA1 111/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.